arginine has been researched along with HbS Disease in 79 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (3.80) | 18.7374 |
1990's | 8 (10.13) | 18.2507 |
2000's | 32 (40.51) | 29.6817 |
2010's | 26 (32.91) | 24.3611 |
2020's | 10 (12.66) | 2.80 |
Authors | Studies |
---|---|
Alpoim, PN; Carvalho, MDG; da Silva, AJ; de Oliveira, MM; Dusse, LMS; Ferreira, LGR; Martins, SR; Mendes, FS; Pinheiro, MB; Rios, DRA; Toledo, SLO | 1 |
Bakshi, N; Dampier, C; Figueroa, J; Khemani, K; Kumari, P; Lane, PA; Leake, D; Morris, CR; Reyes, LZ | 1 |
El-Bradey, MH; Elhawary, EE; Elshanshory, MR; Khedr, SF; Nagy, HM | 1 |
Archer, DR; Brown, LA; Hansen, L; Hurtado, J; Joseph, G; Jun, HW; Lewis, CV; Sellak, H; Taylor, WR | 1 |
Gladwin, MT; Hopper, RK | 1 |
Ahmad, F; Airewele, G; Bakshi, N; Brousseau, DC; Brown, K; Campbell, A; Casper, TC; Chang, T; Chumpitazi, CE; Cohen, DM; Coleman, KD; Dampier, C; Denton, C; Ellison, A; Hatabah, D; Leake, D; Leibovich, S; Morris, CR; Rees, CA; Robinson, M; Thompson, A; Vichinsky, E; Villella, A; Wilkinson, H | 1 |
Brown, LAS; Dampier, CD; Figueroa, J; Harris, F; Kumari, P; Lane, PA; Manoranjithan, S; Mendis, RD; Morris, CR; Reynolds, M; Shiva, S; Watt, A | 1 |
Gladwin, MT; Kim-Shapiro, DB | 1 |
Adeomi, A; Akingbola, TS; Alagbe, AE; Aworanti, OW; Salako, AO | 1 |
Eimunjeze, OP; Jaja, SI; Ogungbemi, SI; Temiye, EO | 1 |
Morris, CR; Shilo, NR | 1 |
Arlet, JB; Avellino, V; Bartolucci, P; Benzerara, Y; Chaignon, M; Djebbar, M; Galacteros, F; Girot, R; Girshovich, A; Grateau, G; Habibi, A; Hammoudi, N; Haymann, JP; Letavernier, E; Levy, P; Lionnet, F; Stankovic Stojanovic, K; Tabibzadeh, N | 1 |
Bluck, L; Cox, SE; Kamuhabwa, A; Makani, J; Marealle, AI; Minzi, O; Prentice, AM; Sasi, P; Siervo, M; Soka, D; Wassel, S | 1 |
Cox, SE; Ellins, EA; Halcox, JP; Johnson, W; Kirkham, FJ; Luca Di Tanna, G; Makani, J; Marealle, AI; Newton, CR; Prentice, AM; Sasi, P; Soka, D | 1 |
Benites, BD; Olalla-Saad, ST | 1 |
Abd El-Hameed, F; Badraia, I; Donia, A; El-Shanshory, M; Mabrouk, M | 1 |
Ansari, M; Gildengorin, G; Kuypers, FA; Lavrisha, L; Morris, CR; Neumayr, L; Stewart, M; Sweeters, N; Vichinsky, EP | 1 |
Anigbogu, CN; Jaja, SI; Kehinde, MO; Ogungbemi, SI | 1 |
Morris, CR | 5 |
Knight-Madden, JM; Martí-Carvajal, AJ; Martinez-Zapata, MJ | 2 |
Biemond, BJ; Brandjes, DP; Duits, AJ; Kappers-Klunne, MC; Landburg, PP; Mac Gillavry, MR; Muskiet, FA; Schnog, JJ; Teerlink, T; van Beers, EJ; van Esser, JW | 1 |
Castro, O; Gladwin, MT; Harris, A; Hauser, KP; Kato, G; Little, JA; Machado, R; Maric, I; Martyr, SE; Morris, CR; Suh, JH; Taylor, J | 1 |
Blackwelder, WC; Hazen, SL; Kato, GJ; Machado, RF; Taylor, JG; Wang, Z | 1 |
McCarty, MF | 1 |
Biemond, BJ; Brandjes, DP; Duits, AJ; Landburg, PP; Muskiet, FA; Schnog, JB; Teerlink, T | 1 |
Billecke, SS; D'Alecy, LG | 1 |
Gardner, RV; Leiva, L; Monjure, H; Scavella, A; Zea, AH | 1 |
Biemond, BJ; Brandjes, DP; Fijnvandraat, K; Nur, E; Otten, HM; Schalkwijk, CG; Schnog, JJ | 1 |
Gladwin, MT; Jain, S | 1 |
Brown, M; Duckworth, L; Froyen, M; Gauger, C; Kissoon, N; Murphy, S; Sandler, E; Sullivan, KJ | 1 |
Baliga, BS; Haynes, J; Mishra, N; Obiako, B | 1 |
Adams-Graves, P; Askin, M; Castaneda, SA; Eberhardt, RT; Faller, DV; McMahon, L; Perrine, SP; Sutton, M; Tamary, H; Wright, EC | 1 |
Cox, SE; Kirkham, FJ; Komba, AN; Makani, J; Newton, CR; Prentice, AM; Soka, D | 1 |
Hardy, KA; Morris, CR; Newaskar, M | 1 |
Fabry, ME; Kaul, DK; Suzuka, SM; Zhang, X | 1 |
Barbosa, MC; Dutra, LL; Elias, DB; Gonçalves, RP; Martins, AM; Rocha, LB; Silva, HF | 1 |
Vichinsky, E | 2 |
Ballas, SK; Davis-Moon, L; Kreshak, AA; Lopez, BL; Ma, XL; Morris, CR | 1 |
Claster, S; Hagar, W; Kepka-Lenhart, D; Kuypers, FA; Machado, L; Morris, CR; Morris, SM; Van Warmerdam, J; Vichinsky, EP | 1 |
Gladwin, MT; Jison, ML | 1 |
Kepka-Lenhart, D; Kuypers, FA; Machado, L; Morris, CR; Morris, SM; van Warmerdam, J; Vichinsky, EP | 1 |
Baliga, BS; Haynes, J; Obiako, B; Ofori-Acquah, S; Pace, B | 1 |
Aslan, M; Freeman, BA | 1 |
Duits, AJ; Jager, EH; Moshage, H; Muskiet, FA; Muskiet, FD; Schnog, JJ; van der Dijs, FP | 1 |
Brunini, TM; Mendes Ribeiro, AC | 1 |
Atweh, GF; Galperin, Y; Ji, X; Li, Q; Liebhaber, SA; Perrine, S; Stamatoyannopoulos, G; Sutton, M; Weinberg, RS | 1 |
Duits, AJ; Muskiet, FA; Schnog, JB; Teerlink, T; van der Dijs, FP | 1 |
Eva, R; Fabry, ME; Fasipe, FR; Ubawike, AE | 1 |
Blackwelder, WC; Gladwin, MT; Hazen, SL; Kato, GJ; Morris, CR; Morris, SM; Poljakovic, M; Sachdev, V; Vichinsky, EP; Wang, X | 1 |
Waugh, WH | 1 |
Cooke, JP; Kielstein, JT | 1 |
Morris, CR; Singer, ST; Walters, MC | 1 |
Dasgupta, T; Hebbel, RP; Kaul, DK | 1 |
Habib, MJ; Millis, RM; Nahavandi, M; Tavakkoli, F; Tavakoli, N; Wyche, MQ | 1 |
Barb, J; Danner, RL; Gladwin, MT; Harris, A; Kato, G; Logun, C; Morris, SM; Munson, PJ; Raghavachari, N; Solomon, MA; Suffredini, AF; Villagra, J; Xu, X | 1 |
Duits, AJ; Landburg, PP; Muskiet, FA; Schnog, JJ; Teerlink, T | 1 |
Dasgupta, T; Fabry, ME; Kaul, DK; Zhang, X | 1 |
Gladwin, MT; Hsu, LL; Krajewski, ML | 1 |
Dover, GJ; Faller, DV; Ginder, GD; Olivieri, NF; Perrine, SP; Vichinsky, EP | 1 |
Bunn, HF | 1 |
Cai, SP; Dover, GH; Faller, DV; Ginder, GD; Ikuta, T; Olivieri, NF; Perrine, SP; Vichinsky, EP; Witkowska, HE | 1 |
Dover, GJ; Ginder, GD; Little, J; Olivieri, NF; Sher, GD; Yang, S | 1 |
Olivieri, NF; Sher, GD | 1 |
Arruda, VR; Condino-Neto, A; Costa, FF; De Nucci, G; Dias-Da-Motta, P; Muscará, MN; Saad, ST | 1 |
Bolton, LL; Cackovic, M; Chung, C; Kerstein, MD | 1 |
Fabry, ME; Kaul, DK; Liu, XD; Nagel, RL | 1 |
Bayne, E; Duckworth, LJ; Freeman, B; Kissoon, N; Lima, JJ; Sandler, E; Sullivan, KJ; Sylvester, JE | 1 |
Rezaei Kalantari, H | 1 |
Fabry, ME; Nagel, RL; Romero, JR; Suzuka, SM | 1 |
Enwonwu, CO; Turner, E; Xu, XX | 1 |
Fales, FW; Grush, OC; Sophianopoulos, AJ; Sophianopoulos, JA; Wilson, JS | 1 |
Levy, HL | 1 |
Cotton, E; Hathaway, W; Solomons, C | 1 |
16 review(s) available for arginine and HbS Disease
Article | Year |
---|---|
Pathways to pulmonary hypertension in sickle cell disease: the search for prevention and early intervention.
Topics: Anemia, Sickle Cell; Arginine; Biomarkers; Blood Coagulation; Echocardiography; Genetic Predisposition to Disease; Hemolysis; Humans; Hypertension, Pulmonary; Hypoxia; Nitric Oxide; Oxidative Stress; Respiratory Function Tests; Risk Assessment | 2017 |
An update on arginine in sickle cell disease.
Topics: Anemia, Sickle Cell; Animals; Arginine; Hemolysis; Humans; Nitric Oxide; Nitric Oxide Synthase Type III | 2019 |
Alterations of the arginine metabolome in sickle cell disease: a growing rationale for arginine therapy.
Topics: Anemia, Sickle Cell; Antisickling Agents; Arginine; Drug Therapy, Combination; Fetal Hemoglobin; Humans; Hydroxyurea; Metabolome; Treatment Outcome | 2014 |
Interventions for treating leg ulcers in people with sickle cell disease.
Topics: Actihaemyl; Anemia, Sickle Cell; Anti-Bacterial Agents; Arginine; Bandages; Butyrates; Carnitine; Humans; Isoxsuprine; Leg Ulcer; Oligopeptides; Randomized Controlled Trials as Topic | 2014 |
Mechanisms of vasculopathy in sickle cell disease and thalassemia.
Topics: Anemia, Sickle Cell; Apolipoproteins; Arginine; Biological Transport; Endothelium, Vascular; Hemolysis; Humans; Inflammation; Kidney Diseases; Nitric Oxide; Nitric Oxide Synthase; Oxidative Stress; Reperfusion Injury; Thalassemia | 2008 |
Asthma management: reinventing the wheel in sickle cell disease.
Topics: Acute Disease; Adult; Anemia, Sickle Cell; Anti-Asthmatic Agents; Arginase; Arginine; Asthma; Black or African American; Chest Pain; Child; Child, Preschool; Combined Modality Therapy; Comorbidity; Erythrocytes, Abnormal; Genetic Predisposition to Disease; Humans; Hypertension, Pulmonary; Hypoxia; Long QT Syndrome; Nitric Oxide; Oxidative Stress; Oxygen Inhalation Therapy; Prevalence; United States | 2009 |
Asthma in sickle cell disease.
Topics: Anemia, Sickle Cell; Arginine; Asthma; Humans; Incidence; Leukotrienes; Lung; Nitric Oxide; Pneumonia | 2011 |
Interventions for treating leg ulcers in people with sickle cell disease.
Topics: Actihaemyl; Anemia, Sickle Cell; Anti-Bacterial Agents; Arginine; Bandages; Butyrates; Carnitine; Humans; Isoxsuprine; Leg Ulcer; Oligopeptides; Randomized Controlled Trials as Topic | 2012 |
Emerging 'A' therapies in hemoglobinopathies: agonists, antagonists, antioxidants, and arginine.
Topics: Anemia, Sickle Cell; Antioxidants; Arginine; Cell Adhesion; Clinical Trials as Topic; Endothelium, Vascular; Hemoglobinopathies; Humans; Inflammation; Iron; Mutation; Nitric Oxide; Oxygen; Research Design; Treatment Outcome | 2012 |
New therapies in sickle cell disease.
Topics: Anemia, Sickle Cell; Animals; Antioxidants; Arginine; Blood Transfusion; Enzyme Inhibitors; Fetal Hemoglobin; Fibrinolytic Agents; Genetic Therapy; Hematopoietic Stem Cell Transplantation; Hemoglobin, Sickle; Humans; Mice; Mice, Transgenic; Models, Animal; Nitric Oxide; Platelet Aggregation Inhibitors | 2002 |
Hemolytic anemia-associated pulmonary hypertension of sickle cell disease and the nitric oxide/arginine pathway.
Topics: Anemia, Hemolytic; Anemia, Sickle Cell; Arginine; Biological Availability; Humans; Hypertension, Pulmonary; Nitric Oxide; Prognosis; Pulmonary Wedge Pressure; Syndrome; Vasodilator Agents | 2003 |
Oxidant-mediated impairment of nitric oxide signaling in sickle cell disease--mechanisms and consequences.
Topics: Anemia, Sickle Cell; Animals; Arginine; Cytoskeletal Proteins; Free Radicals; Humans; Nitric Oxide; Oxidants; Signal Transduction | 2004 |
L-Arginine transport in disease.
Topics: Amino Acid Transport Systems, Basic; Anemia, Sickle Cell; Arginine; Biological Transport; Diabetes Mellitus; Heart Failure; Humans; Hypertension; Kidney Failure, Chronic; Nitric Oxide; Shock, Septic | 2004 |
Clinical hemoglobinopathies: iron, lungs and new blood.
Topics: Anemia, Sickle Cell; Arginine; beta-Thalassemia; Child; Hematopoietic Stem Cell Transplantation; Humans; Hypertension, Pulmonary; Iron Chelating Agents; Iron Overload; Prognosis | 2006 |
[How I treat ... sickle cell anemia: current therapies].
Topics: Anemia, Sickle Cell; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Antisickling Agents; Arginine; Aspirin; Blood Transfusion; Fluid Therapy; Hematopoietic Stem Cell Transplantation; Hemolysis; Humans; Hydroxyurea; Nitric Oxide; Thromboembolism; Transplantation, Homologous | 2001 |
Genetic screening.
Topics: Amino Acid Metabolism, Inborn Errors; Anemia, Sickle Cell; Arginine; Carbohydrate Metabolism, Inborn Errors; Cystinuria; Erythrocytes; Fanconi Syndrome; Galactosemias; Genetics, Population; Glucosephosphate Dehydrogenase; Glycine; Hartnup Disease; Heterozygote; Histidine; Homocystine; Humans; Lysine; Maple Syrup Urine Disease; Mass Screening; Methods; Ornithine; Phenylalanine; Phenylketonurias; Succinates; Tyrosine | 1973 |
11 trial(s) available for arginine and HbS Disease
Article | Year |
---|---|
Safety of intravenous arginine therapy in children with sickle cell disease hospitalized for vaso-occlusive pain: A randomized placebo-controlled trial in progress.
Topics: Administration, Intravenous; Adolescent; Adult; Anemia, Sickle Cell; Arginine; Child; Child, Preschool; Hospitalization; Humans; Pain; Placebo Effect; Prospective Studies; Young Adult | 2022 |
Sickle Cell Disease Treatment with Arginine Therapy (STArT): study protocol for a phase 3 randomized controlled trial.
Topics: Academies and Institutes; Adolescent; Analgesics, Opioid; Anemia, Sickle Cell; Arginine; Child; Clinical Trials, Phase III as Topic; Humans; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Saline Solution; Young Adult | 2023 |
Impact of arginine therapy on mitochondrial function in children with sickle cell disease during vaso-occlusive pain.
Topics: Adolescent; Analgesics, Opioid; Anemia, Sickle Cell; Arginine; Child; Female; Humans; Male; Mitochondria; Oxidative Stress; Pain; Prospective Studies | 2020 |
Renin-angiotensin system blockade promotes a cardio-renal protection in albuminuric homozygous sickle cell patients.
Topics: Adult; Albuminuria; Anemia, Sickle Cell; Angiotensin-Converting Enzyme Inhibitors; Arginine; Biomarkers; Blood Pressure; Creatinine; Female; Glomerular Filtration Rate; Humans; Male; Pulse Wave Analysis; Renin-Angiotensin System; Tricuspid Valve Insufficiency | 2017 |
A randomized, placebo-controlled trial of arginine therapy for the treatment of children with sickle cell disease hospitalized with vaso-occlusive pain episodes.
Topics: Adolescent; Analgesics, Opioid; Anemia, Sickle Cell; Arginine; Child; Double-Blind Method; Female; Hospitalization; Humans; Infusions, Intravenous; Male; Pain; Pain Measurement; Prospective Studies; Treatment Outcome | 2013 |
Effect of oral arginine supplementation on exhaled nitric oxide concentration in sickle cell anemia and acute chest syndrome.
Topics: Acute Chest Syndrome; Acute Disease; Administration, Oral; Adolescent; Anemia, Sickle Cell; Arginine; Aspartic Acid; Breath Tests; Child; Citrulline; Female; Glutamic Acid; Humans; Male; Nitrates; Nitric Oxide; Nitrites; Ornithine; Young Adult | 2010 |
A randomized phase II trial of Arginine Butyrate with standard local therapy in refractory sickle cell leg ulcers.
Topics: Adult; Anemia, Sickle Cell; Arginine; Butyrates; Chronic Disease; Female; Humans; Leg Ulcer; Male; Middle Aged; Prospective Studies; Treatment Outcome; Wound Healing; Young Adult | 2010 |
Arginine therapy: a new treatment for pulmonary hypertension in sickle cell disease?
Topics: Administration, Oral; Adolescent; Adult; Amino Acids; Anemia, Sickle Cell; Arginase; Arginine; Biological Availability; Case-Control Studies; Echocardiography; Female; Humans; Hypertension, Pulmonary; Male; Middle Aged; Nitric Oxide; Ornithine; Oximetry; Pulmonary Wedge Pressure; Treatment Outcome | 2003 |
Hydroxyurea and arginine therapy: impact on nitric oxide production in sickle cell disease.
Topics: Adolescent; Adult; Anemia, Sickle Cell; Antineoplastic Agents; Arginine; Child; Drug Interactions; Drug Therapy, Combination; Female; Free Radical Scavengers; Humans; Hydroxyurea; Male; Nitric Oxide | 2003 |
Butyrate increases the efficiency of translation of gamma-globin mRNA.
Topics: Adult; Anemia, Sickle Cell; Arginine; Butyrates; Fetal Hemoglobin; Globins; Humans; Peptide Chain Initiation, Translational; Protein Biosynthesis; Reticulocytes; RNA, Messenger | 2005 |
A short-term trial of butyrate to stimulate fetal-globin-gene expression in the beta-globin disorders.
Topics: Adolescent; Adult; Anemia, Sickle Cell; Arginine; beta-Thalassemia; Butyrates; Child; Child, Preschool; Female; Fetal Hemoglobin; Globins; Humans; Infusions, Intravenous; Male; RNA, Messenger | 1993 |
52 other study(ies) available for arginine and HbS Disease
Article | Year |
---|---|
Endothelial dysfunction biomarkers in sickle cell disease: is there a role for ADMA and PAI-1?
Topics: Adolescent; Adult; Anemia, Sickle Cell; Arginine; Biomarkers; Child; Cross-Sectional Studies; Endothelium; Female; Humans; Male; Plasminogen Activator Inhibitor 1; Severity of Illness Index; Young Adult | 2022 |
Correlation of Asymmetric Dimethyl Arginine Level to Sickle Retinopathy in Children With Sickle Cell Disease.
Topics: Anemia, Sickle Cell; Arginine; Child; Cross-Sectional Studies; Humans; Retinal Diseases | 2023 |
Increasing nitric oxide bioavailability fails to improve collateral vessel formation in humanized sickle cell mice.
Topics: Anemia, Sickle Cell; Animals; Arginine; Biological Availability; Drinking Water; Hindlimb; Ischemia; Mice; Muscle, Skeletal; Necrosis; Neovascularization, Physiologic; NG-Nitroarginine Methyl Ester; Nitric Oxide; Regional Blood Flow | 2022 |
Revisiting Arginine Therapy for Sickle Cell Acute Vasoocclusive Painful Crisis.
Topics: Anemia, Sickle Cell; Arginine; Child; Child, Hospitalized; Hemodynamics; Humans; Pain; Prospective Studies | 2022 |
Arginine for mitochondrial oxidative enzymopathy.
Topics: Anemia, Sickle Cell; Arginine; Child; Humans; Mitochondria; Oxidative Stress; Pain | 2020 |
Plasma L-Arginine in Sickle Cell Anaemia Patients in Crises and its Correlation with Markers of Severity of Disease.
Topics: Adolescent; Adult; Anemia, Sickle Cell; Arginine; Cross-Sectional Studies; Humans; Middle Aged; Nigeria; Plasma; Quality of Life; Severity of Illness Index; Young Adult | 2021 |
Blood pressure, hematologic and biochemical changes following L-arginine supplementation in children with sickle cell anaemia already on hydroxyurea therapy.
Topics: Anemia, Sickle Cell; Arginine; Blood Pressure; Child; Dietary Supplements; Humans; Hydroxyurea | 2020 |
A pilot study of a non-invasive oral nitrate stable isotopic method suggests that arginine and citrulline supplementation increases whole-body NO production in Tanzanian children with sickle cell disease.
Topics: Administration, Oral; Anemia, Sickle Cell; Arginine; Child; Citrulline; Dietary Supplements; Female; Humans; Male; Nitrates; Nitric Oxide; Nitrogen Isotopes; Pilot Projects; Tanzania | 2018 |
Ready-to-use food supplement, with or without arginine and citrulline, with daily chloroquine in Tanzanian children with sickle-cell disease: a double-blind, random order crossover trial.
Topics: Anemia, Sickle Cell; Arginine; Child; Chloroquine; Citrulline; Cross-Over Studies; Dietary Supplements; Double-Blind Method; Female; Humans; Male; Tanzania | 2018 |
Asymmetric dimethylarginine levels in children with sickle cell disease and its correlation to tricuspid regurgitant jet velocity.
Topics: Adolescent; Anemia, Sickle Cell; Arginine; Blood Transfusion; Case-Control Studies; Child; Cross-Sectional Studies; Echocardiography, Doppler; Female; Hemolysis; Humans; Hypertension, Pulmonary; Male; Risk Factors; Tricuspid Valve Insufficiency | 2013 |
L-arginine increases nitric oxide and attenuates pressor and heart rate responses to change in posture in sickle cell anemia subjects.
Topics: Anemia, Sickle Cell; Arginine; Heart Rate; Humans; Nitric Oxide; Posture | 2013 |
Arginine Therapy Shows Promise for Treatment of Sickle Cell Disease Clinical Subphenotypes of Hemolysis and Arginine Deficiency.
Topics: Anemia, Sickle Cell; Arginine; Cell Death; Hemolysis; Humans; Nitric Oxide | 2017 |
Association of asymmetric dimethylarginine with sickle cell disease-related pulmonary hypertension.
Topics: Adult; Anemia, Sickle Cell; Arginine; Biomarkers; Female; Humans; Hypertension, Pulmonary; Male; Middle Aged | 2008 |
Hematologic, biochemical, and cardiopulmonary effects of L-arginine supplementation or phosphodiesterase 5 inhibition in patients with sickle cell disease who are on hydroxyurea therapy.
Topics: Adult; Anemia, Sickle Cell; Arginase; Arginine; beta-Globins; Citrulline; Cyclic Nucleotide Phosphodiesterases, Type 5; Female; Fetal Hemoglobin; Humans; Hydroxyurea; Male; Middle Aged; Ornithine; Phosphodiesterase Inhibitors; Piperazines; Purines; Reticulocyte Count; Sildenafil Citrate; Sulfones | 2009 |
Endogenous nitric oxide synthase inhibitors in sickle cell disease: abnormal levels and correlations with pulmonary hypertension, desaturation, haemolysis, organ dysfunction and death.
Topics: Anemia, Sickle Cell; Arginine; Case-Control Studies; Citrulline; Follow-Up Studies; Hemolysis; Humans; Hypertension, Pulmonary; Kidney Diseases; Linear Models; Nitric Oxide Synthase; omega-N-Methylarginine; Oxygen; Proportional Hazards Models; Risk; Survival Rate | 2009 |
Potential utility of full-spectrum antioxidant therapy, citrulline, and dietary nitrate in the management of sickle cell disease.
Topics: Anemia, Sickle Cell; Animals; Antioxidants; Arginine; Citrulline; Hemoglobins; Humans; Models, Biological; Nitrates; Nitric Oxide; Oxidative Stress; Vegetables | 2010 |
Plasma asymmetric dimethylarginine concentrations in sickle cell disease are related to the hemolytic phenotype.
Topics: Adult; Albuminuria; Anemia, Sickle Cell; Arginine; beta-Thalassemia; Cholelithiasis; Female; Hemolysis; Humans; Hypertension, Pulmonary; Leg Ulcer; Male; Middle Aged; Nitric Oxide; Osteonecrosis; Phenotype; Priapism; Retinal Diseases; Sickle Cell Trait; Young Adult | 2010 |
Massive quantities of asymmetric dimethylarginine (ADMA) are incorporated in red blood cell proteins and may be released by proteolysis following hemolytic stress.
Topics: Anemia, Sickle Cell; Arginine; Blood Proteins; Erythrocytes; Hemolysis; Humans | 2010 |
Effect of L-arginine supplementation on immune responsiveness in patients with sickle cell disease.
Topics: Adolescent; Anemia, Sickle Cell; Arginine; Case-Control Studies; CD3 Complex; Cells, Cultured; Child; Female; Humans; Immunity; Lymphocyte Activation; Male; Phytohemagglutinins; T-Lymphocyte Subsets; Up-Regulation; Young Adult | 2010 |
Plasma levels of advanced glycation end products are associated with haemolysis-related organ complications in sickle cell patients.
Topics: Adolescent; Adult; Anemia, Sickle Cell; Arginine; Biomarkers; Female; Glycation End Products, Advanced; Hemolysis; Humans; Lysine; Male; Middle Aged; Oxidative Stress; Young Adult | 2010 |
Arginine metabolism and nitric oxide bioavailability in sickle cell disease.
Topics: Anemia, Sickle Cell; Arginine; Endothelial Cells; Hemoglobins; Humans; Nitric Oxide; Nitric Oxide Synthase Type III | 2010 |
Combined effects of arginine and hydroxyurea on BFU-E derived colony growth and HbF synthesis in erythroid progenitors isolated from sickle cell blood.
Topics: Anemia, Sickle Cell; Arginine; Cell Proliferation; Erythroid Precursor Cells; Fetal Hemoglobin; Humans; Hydroxyurea; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase | 2010 |
Global arginine bioavailability in Tanzanian sickle cell anaemia patients at steady-state: a nested case control study of deaths versus survivors.
Topics: Adolescent; Adult; Anemia, Sickle Cell; Arginine; Biological Availability; Case-Control Studies; Cohort Studies; Female; Hemoglobin, Sickle; Humans; Male; Prospective Studies; Retrospective Studies; Survival Analysis; Tanzania; Young Adult | 2011 |
Antisickling fetal hemoglobin reduces hypoxia-inducible factor-1α expression in normoxic sickle mice: microvascular implications.
Topics: alpha-Globins; Anemia, Sickle Cell; Animals; Arginine; Arterioles; beta-Globins; Blood Pressure; Disease Models, Animal; Down-Regulation; Endothelin-1; Fetal Hemoglobin; Heme Oxygenase-1; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Inflammation; Membrane Proteins; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Microcirculation; Nitric Oxide; Regional Blood Flow; Vascular Endothelial Growth Factor A; Vasodilation | 2013 |
L-arginine as an adjuvant drug in the treatment of sickle cell anaemia.
Topics: Adjuvants, Pharmaceutic; Anemia, Sickle Cell; Arginine; Erythrocyte Indices; Humans; Nitrites; Oxidative Stress | 2013 |
L-arginine levels are diminished in adult acute vaso-occlusive sickle cell crisis in the emergency department.
Topics: Acute Disease; Adult; Anemia, Sickle Cell; Arginine; Biomarkers; Constriction, Pathologic; Humans; Nitric Oxide; Pain Measurement; Vascular Diseases | 2003 |
Zileuton induces hemoglobin F synthesis in erythroid progenitors: role of the L-arginine-nitric oxide signaling pathway.
Topics: Anemia, Sickle Cell; Arginine; Case-Control Studies; Cells, Cultured; Cyclic GMP; Dose-Response Relationship, Drug; Erythroid Precursor Cells; Fetal Hemoglobin; Gene Expression Regulation; Humans; Hydroxyurea; K562 Cells; Nitric Oxide; Nitric Oxide Synthase; Signal Transduction | 2004 |
Evidence for a metabolic shift of arginine metabolism in sickle cell disease.
Topics: Adult; Amino Acids; Anemia, Sickle Cell; Arginase; Arginine; Case-Control Studies; Hemoglobin A; Hemoglobin, Sickle; Hemoglobins; Humans; Middle Aged; Statistics as Topic | 2004 |
Plasma levels of asymmetric dimethylarginine (ADMA), an endogenous nitric oxide synthase inhibitor, are elevated in sickle cell disease.
Topics: Adult; Anemia, Sickle Cell; Arginine; Female; Hemoglobin, Sickle; Humans; Male; Middle Aged; Nitric Oxide; Nitric Oxide Synthase; Vascular Cell Adhesion Molecule-1 | 2005 |
Arginine supplementation improves rotorod performance in sickle transgenic mice.
Topics: Anemia, Sickle Cell; Animals; Arginine; Diet; Disease Models, Animal; Hemoglobin A; Hemoglobin, Sickle; Homozygote; Humans; Mice; Mice, Inbred C57BL; Mice, Transgenic; Motor Activity; Nitric Oxide; Vasodilation | 2004 |
Dysregulated arginine metabolism, hemolysis-associated pulmonary hypertension, and mortality in sickle cell disease.
Topics: Adult; Aged; Amino Acids; Anemia, Sickle Cell; Arginase; Arginine; Case-Control Studies; Female; Humans; Hypertension, Pulmonary; Male; Middle Aged; Nitric Oxide; Ornithine; Proportional Hazards Models | 2005 |
Arginine metabolism, pulmonary hypertension, and sickle cell disease.
Topics: Anemia, Sickle Cell; Arginase; Arginine; Citrulline; Dietary Supplements; Humans; Hypertension, Pulmonary | 2005 |
Arginine metabolism, pulmonary hypertension, and sickle cell disease.
Topics: Anemia, Sickle Cell; Arginase; Arginine; Humans; Hypertension, Pulmonary; Nitric Oxide Synthase | 2005 |
New strategies for the treatment of pulmonary hypertension in sickle cell disease : the rationale for arginine therapy.
Topics: Anemia, Sickle Cell; Arginase; Arginine; Humans; Hypertension, Pulmonary; Nitric Oxide; Prospective Studies | 2006 |
Protective effect of arginine on oxidative stress in transgenic sickle mouse models.
Topics: Anemia, Sickle Cell; Animals; Antioxidants; Arginine; Catalase; Dietary Supplements; Disease Models, Animal; Glutathione; Glutathione Peroxidase; Lipid Peroxidation; Mice; Mice, Inbred C57BL; Mice, Transgenic; NG-Nitroarginine Methyl Ester; Nitric Oxide; Oxidative Stress; Superoxide Dismutase | 2006 |
Effects of hydroxyurea and L-arginine on the production of nitric oxide metabolites in cultures of normal and sickle erythrocytes.
Topics: Adolescent; Adult; Anemia, Sickle Cell; Arginine; Cells, Cultured; Erythrocytes; Erythrocytes, Abnormal; Female; Hemoglobin A; Hemoglobin, Sickle; Humans; Hydrogen Peroxide; Hydroxyurea; Male; Middle Aged; Nitric Oxide; Nitric Oxide Donors; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; omega-N-Methylarginine; Oxidative Stress; Sampling Studies | 2006 |
Amplified expression profiling of platelet transcriptome reveals changes in arginine metabolic pathways in patients with sickle cell disease.
Topics: Adult; Anemia, Sickle Cell; Arginase; Arginine; Black People; Blood Platelets; Female; Gene Expression Profiling; Humans; Male; Middle Aged; Models, Biological; Nitric Oxide; Nucleic Acid Amplification Techniques; Oligonucleotide Array Sequence Analysis; Polyamines; Transcription, Genetic | 2007 |
Plasma concentrations of asymmetric dimethylarginine, an endogenous nitric oxide synthase inhibitor, are elevated in sickle cell patients but do not increase further during painful crisis.
Topics: Adolescent; Adult; Anemia, Sickle Cell; Arginine; Child; Enzyme Inhibitors; Female; Humans; Male; Middle Aged; Nitric Oxide Synthase; Stereoisomerism | 2008 |
Arginine therapy of transgenic-knockout sickle mice improves microvascular function by reducing non-nitric oxide vasodilators, hemolysis, and oxidative stress.
Topics: Acetylcholine; Anemia, Sickle Cell; Animals; Arginine; Citrulline; Cyclooxygenase 2; Dinoprostone; Disease Models, Animal; Enzyme Inhibitors; Globins; Heme Oxygenase-1; Hemodynamics; Hemoglobins; Hemolysis; Humans; Membrane Proteins; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Microcirculation; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Donors; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Nitroprusside; Oxidative Stress; Tyrosine; Vasodilator Agents | 2008 |
The proverbial chicken or the egg? Dissection of the role of cell-free hemoglobin versus reactive oxygen species in sickle cell pathophysiology.
Topics: Anemia, Sickle Cell; Animals; Arginine; Disease Models, Animal; Hemodynamics; Hemoglobins; Hemolysis; Humans; Microcirculation; Nitric Oxide; Nitric Oxide Donors; Nitric Oxide Synthase; Oxidative Stress; Tyrosine; Vasodilator Agents | 2008 |
Butyrate derivatives. New agents for stimulating fetal globin production in the beta-globin disorders.
Topics: Adolescent; Adult; Amides; Anemia, Sickle Cell; Animals; Arginine; beta-Thalassemia; Butyrates; Child; Child, Preschool; Fetal Hemoglobin; Globins; Humans; Promoter Regions, Genetic | 1994 |
Reversing ontogeny.
Topics: Anemia, Sickle Cell; Arginine; beta-Thalassemia; Butyrates; Fetal Hemoglobin; Globins; Humans; Hydroxyurea | 1993 |
Extended therapy with intravenous arginine butyrate in patients with beta-hemoglobinopathies.
Topics: Adolescent; Adult; Anemia, Sickle Cell; Arginine; beta-Thalassemia; Biomarkers; Butyrates; Child; Child, Preschool; Female; Hemoglobins; Humans; Infusions, Intravenous; Male | 1995 |
Rapid healing of chronic leg ulcers during arginine butyrate therapy in patients with sickle cell disease and thalassemia.
Topics: Adult; Anemia, Sickle Cell; Arginine; Butyrates; Female; Hemoglobins, Abnormal; Humans; Leg Ulcer; Thalassemia | 1994 |
The release of nitric oxide and superoxide anion by neutrophils and mononuclear cells from patients with sickle cell anaemia.
Topics: Adolescent; Adult; Anemia, Sickle Cell; Arginine; Female; Humans; Male; Neutrophils; NG-Nitroarginine Methyl Ester; Nitric Oxide; Platelet Aggregation; Superoxide Dismutase; Superoxides | 1996 |
Leg ulceration in the sickle cell patient.
Topics: Adolescent; Adult; Anemia, Sickle Cell; Arginine; Bandages, Hydrocolloid; Butyrates; Colloids; Combined Modality Therapy; Cost-Benefit Analysis; Erythropoietin; Female; Hospital Costs; Humans; Leg Ulcer; Length of Stay; Male; Occlusive Dressings; Recombinant Proteins; Recurrence; Retrospective Studies; Wound Healing | 1998 |
Impaired nitric oxide-mediated vasodilation in transgenic sickle mouse.
Topics: Anemia, Sickle Cell; Animals; Arginine; Blood Pressure; Colforsin; Cyclooxygenase Inhibitors; Endothelium, Vascular; Enzyme Inhibitors; Hemoglobin, Sickle; Humans; Indomethacin; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microcirculation; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Vasodilation; Vasodilator Agents | 2000 |
Low exhaled nitric oxide and a polymorphism in the NOS I gene is associated with acute chest syndrome.
Topics: Acute Disease; Adolescent; Anemia, Sickle Cell; Arginine; Breath Tests; Child; Citrulline; Forced Expiratory Volume; Genotype; Humans; Lung Diseases; Nitrates; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Nitrites; Polymorphism, Genetic; Syndrome; Trinucleotide Repeats; Vital Capacity | 2001 |
Arginine supplementation of sickle transgenic mice reduces red cell density and Gardos channel activity.
Topics: Anemia, Sickle Cell; Animals; Arginine; Citrulline; Disease Models, Animal; Erythrocyte Count; Erythrocytes; Hemoglobins; Humans; Kinetics; Mice; Mice, Transgenic; Oxygen; Potassium; Potassium Channels, Calcium-Activated | 2002 |
Nitrogen metabolism in sickle cell anemia: free amino acids in plasma and urine.
Topics: Adult; Amino Acids; Anemia, Sickle Cell; Arginine; Humans; Nitrogen | 1990 |
Two new antisickling agents and the use of amino acid salts.
Topics: Anemia, Sickle Cell; Arginine; Aspartic Acid; Drug Synergism; Edetic Acid; Glucose; Glutamates; Hemoglobins, Abnormal; Homozygote; Humans; Hydrogen-Ion Concentration; Lysine; Osmolar Concentration | 1974 |
L-arginine, the sickling phenomenon, and cystic fibrosis.
Topics: Aerosols; Anemia, Sickle Cell; Arginine; Cystic Fibrosis; Fever; Humans | 1972 |